<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1382755</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Risk stratification and survival time of patients with gram-negative bacillary pneumonia in the intensive care unit</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liao</surname>
<given-names>Qiu-Xia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Feng</surname>
<given-names>Zhi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhuo</surname>
<given-names>Hui-Chang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2649811"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Ye</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Peng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Hai-Rong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2357502"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Intensive Care Unit, First Affiliated Hospital of Fujian Medical University</institution>, <addr-line>Fuzhou, Fujian</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Intensive Care Unit, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital</institution>, <addr-line>Fuzhou, Fujian</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Thoracic Surgery, First Affiliated Hospital of Fujian Medical University</institution>, <addr-line>Fuzhou, Fujian</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: William Bain, University of Pittsburgh, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Nazan Tuna, Namik Kemal University, T&#xfc;rkiye</p>
<p>Hiam Naiditch, University of Pittsburgh, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Hui-Chang Zhuo, <email xlink:href="mailto:zhuohuichang@163.com">zhuohuichang@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1382755</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Liao, Feng, Zhuo, Zhou, Huang and Lin</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Liao, Feng, Zhuo, Zhou, Huang and Lin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Pneumonia is a common infection in the intensive care unit (ICU), and gram-negative bacilli are the most common bacterial cause. The purpose of the study was to investigate the risk factors for 30-day mortality in patients with gram-negative bacillary pneumonia in the ICU, construct a predictive model, and stratify patients based on risk to assess their short-term survival.</p>
</sec>
<sec>
<title>Methods</title>
<p>Patients admitted to the ICU with gram-negative bacillary pneumonia at Fujian Medical University Affiliated First Hospital between January 2018 and September 2020 were selected. Patients were divided into deceased and survivor groups based on whether death occurred within 30 days. Multifactorial logistic regression analysis was used to identify independent risk factors for 30-day mortality in these patients, and a predictive nomogram model was constructed based on these factors. Patients were categorized into low-, medium-, and high-risk groups according to the model's predicted probability, and Kaplan-Meier survival curves were plotted to assess short-term survival.</p>
</sec>
<sec>
<title>Results</title>
<p>The study included 305 patients. Lactic acid (odds ratio [OR], 1.524, 95% CI: 1.057-2.197), tracheal intubation (OR: 4.202, 95% CI: 1.092-16.169), and acute kidney injury (OR:4.776, 95% CI: 1.632-13.978) were identified as independent risk factors for 30-day mortality. A nomogram prediction model was established based on these three factors. Internal validation of the model showed a Hosmer-Lemeshow test result of X2=5.770, P=0.834, and an area under the ROC curve of 0.791 (95% CI: 0.688-0.893). Bootstrap resampling of the original data 1000 times yielded a C-index of 0.791, and a decision curve analysis indicated a high net benefit when the threshold probability was between 15%-90%. The survival time for low-, medium-, and high-risk patients was 30 (30, 30), 30 (16.5, 30), and 17 (11, 27) days, respectively, which were significantly different.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Lactic acid, tracheal intubation, and acute kidney injury were independent risk factors for 30-day mortality in patients in the ICU with gram-negative bacillary pneumonia. The predictive model constructed based on these factors showed good predictive performance and helped assess short-term survival, facilitating early intervention and treatment.</p>
</sec>
</abstract>
<kwd-group>
<kwd>acute kidney injury</kwd>
<kwd>gram-negative bacillary pneumonia</kwd>
<kwd>lactic acid</kwd>
<kwd>logistic models</kwd>
<kwd>nomogram</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="34"/>
<page-count count="9"/>
<word-count count="4895"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Clinical Infectious Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Pneumonia is the most common infection in the intensive care unit (ICU) (<xref ref-type="bibr" rid="B30">Pugh et&#xa0;al., 2015</xref>). Currently, gram-negative bacilli are the most common pathogenic bacteria causing ICU pneumonia (<xref ref-type="bibr" rid="B13">Feng et&#xa0;al., 2023</xref>). These bacteria have a range of resistance mechanisms against antimicrobial drugs, such as increased efflux pumps, alteration of drug binding sites, reduced permeability of the bacterial outer membrane, and production of degrading enzymes, resulting in strong antibiotic resistance (<xref ref-type="bibr" rid="B23">Ma et&#xa0;al., 2009</xref>). In recent years, the incidence of pneumonia caused by gram-negative bacilli has increased, mainly due to <italic>K. pneumoniae</italic>, <italic>A. baumannii</italic>, and <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="B17">Guzek et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B12">Durdu et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B34">Solmaz and Kal&#x131;n, 2021</xref>; <xref ref-type="bibr" rid="B2">Assefa, 2022</xref>).</p>
<p>Gram-negative bacilli can be isolated from approximately 67.1% of ICU patients with pneumonia, of which <italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> account for over 80% of these cases (<xref ref-type="bibr" rid="B32">Sader et&#xa0;al., 2018</xref>). With the widespread use of broad-spectrum antibiotics, the incidence of infections with multidrug-resistant gram-negative bacilli has increased (<xref ref-type="bibr" rid="B8">Cill&#xf3;niz et&#xa0;al., 2019</xref>), significantly worsening the survival rate of infected patients. Gram-negative bacilli infections have become a major challenge to global public health (<xref ref-type="bibr" rid="B19">Kanj et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B11">Dettori et&#xa0;al., 2023</xref>). Studies have shown that the mortality rate of gram-negative bacillary pneumonia is 14.5%-32% (<xref ref-type="bibr" rid="B14">Feng et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B20">Kofteridis et&#xa0;al., 2020</xref>). Patients in the ICU are often critically ill, with shorter survival times and higher mortality rates. In addition, previous studies (<xref ref-type="bibr" rid="B5">Casale et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B7">Cheema et&#xa0;al., 2023</xref>) showed that death in ICU patients infected with gram-negative bacillary pneumonia is related to clinical characteristics and therapeutic measures, but the predictive efficiency of various factors varies greatly, and no effective prediction model for the short-term mortality of these patients exists, nor does an evaluation of their short-term survival time. Thus, there is an important need for predictive models to determine the short-term mortality and survival analysis of ICU patients with gram-negative bacillary pneumonia.</p>
<p>To bridge this gap in literature, we designed this study to retrospectively analyze the case data of ICU patients with gram-negative bacillary pneumonia, identify the risk factors for 30-day mortality, establish a predictive model, stratify the risks, and assess patient survival time. The proposed model could allow clinicians to initiate early intervention and guide clinical diagnosis and treatment, thereby improving patient therapeutic outcomes.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Study participants</title>
<p>In this retrospective study conducted at the ICU of the First Affiliated Hospital of Fujian Medical University between January 2018 and September 2020, patients diagnosed with gram-negative bacillary pneumonia were included. The study&#x2019;s inclusion criteria required patients to meet the diagnostic criteria for pneumonia, as outlined by <xref ref-type="bibr" rid="B18">Hunton (2019)</xref>, and to have gram-negative bacilli cultured from their first sputum sample collected upon ICU admission. Exclusion criteria encompassed individuals under 18 years of age or those with incomplete clinical data. Additionally, to distinguish between colonization and infection, patients were excluded if they exhibited mere colonization by gram-negative bacilli. Only patients presenting clear signs of infection, such as elevated inflammatory markers and clinical symptoms consistent with infection, were included. To ensure the reliability of sputum cultures, concurrent bacterial smear tests were conducted, and sputum samples were deemed suitable for culture if they met specific criteria, including the presence of &#x2264;10 squamous epithelial cells and &#x2265;25 leukocytes per field under low magnification, thereby minimizing contamination risk and ensuring the clinical relevance of cultured organisms.</p>
<p>The endpoint of the study was either patient discharge or death. This study complied with standard medical ethics guidelines and was approved by the Medical Ethics Committee of the First Affiliated Hospital of Fujian Medical University [2015] 084&#x2013;1. Informed consent was obtained from all participants.</p>
<p>Moreover, it should be noted that while our study focused on gram-negative bacillary pneumonia cases from January 2018 to September 2020, it is important to note that the impact of SARS-CoV-2 infection during this timeframe was likely limited due to stringent infectious disease control measures in place until January 2023.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Collection of clinical data</title>
<p>The following clinical data were collected from the patients: sex; age; underlying diseases such as hypertension, diabetes, coronary heart disease, malignant tumors, cerebral infarction, heart failure, and chronic renal failure; Charlson comorbidity index score; use of glucocorticoids, deep vein catheterization, surgery, tracheal intubation, continuous renal replacement therapy, and mechanical ventilation during hospitalization; history of acute kidney injury, duration of mechanical ventilation, liver function abnormalities, and septic shock during hospitalization; SOFA score, APACHE II score, Glasgow score, white blood cell count, platelet count, hemoglobin, procalcitonin, C-reactive protein, blood lactate, oxygenation index, creatinine, activated prothrombin time, prothrombin time, fibrinogen, and D-dimer on the first day of ICU admission.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Relevant definitions</title>
<p>The SOFA score (<xref ref-type="bibr" rid="B1">Arakawa et&#xa0;al., 2021</xref>) refers to the Sequential Organ Failure Assessment, one of the most used scores in the ICU, and is often used to assess the severity of a patient&#x2019;s condition. The APACHE II score (<xref ref-type="bibr" rid="B27">Naved et&#xa0;al., 2011</xref>) consists of an acute physiology score, age score, and chronic health score and is a predictor of mortality in patients in the ICU. Acute kidney injury (<xref ref-type="bibr" rid="B29">Palevsky et&#xa0;al., 2013</xref>) referred to any of the following conditions: 1. An increase in blood creatinine &#x2265;0.3 mg/dL (26.5 mmol/L) within 48 h; 2. An increase in blood creatinine to 1.5 times the baseline value within seven days; and 3. Urine output was &lt;0.5 mL/kg/h, lasting for 6 h.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Statistical analysis</title>
<p>Data analysis was performed using StataSE15.0. Continuous variables that conformed to a normal distribution were expressed as mean &#xb1; standard deviation and tested using <italic>t</italic>-tests. Non-normally distributed continuous variables were expressed as medians (interquartile ranges) and tested using the Mann-Whitney U test.</p>
<p>To develop the multivariate logistic regression model, we designated the 30-day mortality of the investigated ICU patients as the dependent variable. Initially, univariate analyses were conducted to screen potential predictors of mortality, with variables showing significant associations (P &lt; 0.05) being considered for inclusion in the multivariate model. Additionally, variables deemed clinically relevant based on professional knowledge and literature review were also considered. Then, a stepwise forward selection process with a significance level set at P &lt; 0.05 was used to identify the final predictors included in the mode to ensure that only variables contributing significantly to the prediction of 30-day mortality were included in the final model.</p>
<p>Based on the obtained independent variables, a nomogram was drawn to visualize the prediction model, and a receiver operating characteristic (ROC) curve was used to evaluate the discriminative ability of the model. The Hosmer-Lemeshow test was used to determine the model&#x2019;s stability, and the decision curve analysis was used to assess the clinical utility of the model. Patients were stratified by risk based on the model&#x2019;s score and predicted probability and three Kaplan-Meier survival curves were drawn. Statistical significance was set at P &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Bacterial distribution in ICU patients with gram-negative bacillary pneumonia</title>
<p>The bacterial strains infecting ICU patients with gram-negative bacillary pneumonia were <italic>Klebsiella pneumoniae</italic> in 180 cases (59.0%), <italic>Acinetobacter baumannii</italic> in 73 (23.9%), <italic>P. aeruginosa</italic> in 28 (9.2%), <italic>E. coli</italic> in 14 (4.6%), <italic>Stenotrophomonas maltophilia</italic> in 2 (0.7%), <italic>Serratia marcescens</italic> in 2 (0.7%), and other gram-negative bacteria in 6 (1.9%) (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Bacterial Distribution in ICU Patients with Gram-Negative Bacillary Pneumonia.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="left">Bacterial Strain</th>
<th valign="middle" align="center">Number (N=305)</th>
<th valign="middle" align="center">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">
<italic>Klebsiella pneumoniae</italic>
</td>
<td valign="middle" align="center">180</td>
<td valign="middle" align="center">59.0%</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Acinetobacter baumannii</italic>
</td>
<td valign="middle" align="center">73</td>
<td valign="middle" align="center">23.9%</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Pseudomonas aeruginosa</italic>
</td>
<td valign="middle" align="center">28</td>
<td valign="middle" align="center">9.2%</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Escherichia coli</italic>
</td>
<td valign="middle" align="center">14</td>
<td valign="middle" align="center">4.6%</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Stenotrophomonas maltophilia</italic>
</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">0.7%</td>
</tr>
<tr>
<td valign="bottom" align="left">
<italic>Serratia marcescens</italic>
</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">0.7%</td>
</tr>
<tr>
<td valign="bottom" align="left">Other gram-negative bacteria</td>
<td valign="middle" align="center">6</td>
<td valign="middle" align="center">1.9%</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Baseline characteristics</title>
<p>During the study period from January 2018 to September 2020, a total of 508 patients with pulmonary infections were admitted to the ICU of the First Affiliated Hospital of Fujian Medical University. Among them, 2 patients were excluded due to age &lt;18 years and 10 patients were excluded due to incomplete clinical data. Additionally, 191 patients were admitted for pneumonia due to reasons other than gram-negative bacillary pneumonia. Ultimately, 305 patients with gram-negative bacillary pneumonia were included in our study, comprising 242 males and 63 females. The study flow chart is shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flow chart.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1382755-g001.tif"/>
</fig>
<p>The patients were grouped based on overall survival within 30 days, with 240 (78.7%) and 65 (21.3%) in the survivor and deceased groups, respectively. Patients in the deceased group had significantly higher rates of septic shock, hypoalbuminemia, chronic renal insufficiency, and acute kidney injury than those in the survivor group. They also had higher SOFA and APACHE II scores and an increased likelihood of undergoing invasive procedures such as central venous catheterization, tracheal intubation, and continuous renal replacement therapy. The incidence of carbapenem-resistant gram-negative bacteria was higher, hemoglobin levels were significantly lower, and procalcitonin, interleukin-6, lactate, and serum creatinine levels were markedly increased. Activated partial thromboplastin and prothrombin times were extended, D-dimer levels were elevated, mechanical ventilation time was prolonged, and hospital and ICU stays were both significantly shorter (P &lt; 0.05). No statistically significant differences were observed between the two groups in terms of sex, age, hypertension, malignancy, coronary artery disease, diabetes, stroke, Charlson comorbidity index score, hospital-acquired pneumonia, history of corticosteroid use, surgical history, white blood cell count, C-reactive protein level, oxygenation index, bilirubin level, Glasgow Coma Scale score, or fibrinogen level (P &#x2265; 0.05, <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). In regard to the incidence rate of bloodstream infections, our results showed that the incidence rate of bloodstream infections was found to be 9/65 (13.85%) in the deceased group and 14/240 (5.83%) in the survivor group, indicating a significantly higher rate in the deceased group compared to the surviving group (P &lt; 0.030).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Baseline characteristics of patients in the survivor and deceased groups.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Variable</th>
<th valign="top" align="left">Survivor Group<break/>(N=240)</th>
<th valign="top" align="left">Deceased Group<break/>(N=65)</th>
<th valign="top" align="left">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">Sex (Female)</td>
<td valign="bottom" align="left">45 (18.8%)</td>
<td valign="bottom" align="left">18 (27.7%)</td>
<td valign="bottom" align="left">0.114</td>
</tr>
<tr>
<td valign="bottom" align="left">Age (Years)</td>
<td valign="bottom" align="left">64.00 (52.00, 75.00)</td>
<td valign="bottom" align="left">65.00 (53.00, 76.00)</td>
<td valign="bottom" align="left">0.431</td>
</tr>
<tr>
<td valign="bottom" align="left">Hypertension</td>
<td valign="bottom" align="left">136 (56.7%)</td>
<td valign="bottom" align="left">40 (61.5%)</td>
<td valign="bottom" align="left">0.481</td>
</tr>
<tr>
<td valign="bottom" align="left">Malignant Tumor</td>
<td valign="bottom" align="left">30 (12.5%)</td>
<td valign="bottom" align="left">13 (20.0%)</td>
<td valign="bottom" align="left">0.123</td>
</tr>
<tr>
<td valign="bottom" align="left">Coronary Heart Disease</td>
<td valign="bottom" align="left">17 (7.1%)</td>
<td valign="bottom" align="left">8 (12.3%)</td>
<td valign="bottom" align="left">0.173</td>
</tr>
<tr>
<td valign="bottom" align="left">Diabetes</td>
<td valign="bottom" align="left">66 (27.5%)</td>
<td valign="bottom" align="left">15 (23.1%)</td>
<td valign="bottom" align="left">0.474</td>
</tr>
<tr>
<td valign="bottom" align="left">Cerebral Infarction</td>
<td valign="bottom" align="left">54 (22.5%)</td>
<td valign="bottom" align="left">14 (21.5%)</td>
<td valign="bottom" align="left">0.859</td>
</tr>
<tr>
<td valign="bottom" align="left">Septic Shock</td>
<td valign="bottom" align="left">38 (15.8%)</td>
<td valign="bottom" align="left">21 (32.3%)</td>
<td valign="bottom" align="left">0.003</td>
</tr>
<tr>
<td valign="bottom" align="left">Hypoalbuminemia</td>
<td valign="bottom" align="left">89 (37.1%)</td>
<td valign="bottom" align="left">35 (53.8%)</td>
<td valign="bottom" align="left">0.015</td>
</tr>
<tr>
<td valign="bottom" align="left">Chronic Renal Failure</td>
<td valign="bottom" align="left">21 (8.8%)</td>
<td valign="bottom" align="left">12 (18.5%)</td>
<td valign="bottom" align="left">0.025</td>
</tr>
<tr>
<td valign="bottom" align="left">Heart Failure</td>
<td valign="bottom" align="left">33 (13.8%)</td>
<td valign="bottom" align="left">10 (15.4%)</td>
<td valign="bottom" align="left">0.737</td>
</tr>
<tr>
<td valign="bottom" align="left">Acute Kidney Injury</td>
<td valign="bottom" align="left">81 (33.8%)</td>
<td valign="bottom" align="left">51 (78.5%)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">Hospital-acquired Pneumonia</td>
<td valign="bottom" align="left">223 (92.9%)</td>
<td valign="bottom" align="left">62 (95.4%)</td>
<td valign="bottom" align="left">0.476</td>
</tr>
<tr>
<td valign="bottom" align="left">bloodstream infections</td>
<td valign="bottom" align="left">14(5.83%)</td>
<td valign="bottom" align="left">9(13.85%)</td>
<td valign="bottom" align="left">0.030</td>
</tr>
<tr>
<td valign="bottom" align="left">History of Corticosteroid Use</td>
<td valign="bottom" align="left">63 (26.3%)</td>
<td valign="bottom" align="left">19 (29.2%)</td>
<td valign="bottom" align="left">0.631</td>
</tr>
<tr>
<td valign="bottom" align="left">Central Venous Catheterization</td>
<td valign="bottom" align="left">119 (49.6%)</td>
<td valign="bottom" align="left">43 (66.2%)</td>
<td valign="bottom" align="left">0.018</td>
</tr>
<tr>
<td valign="bottom" align="left">Surgical History</td>
<td valign="bottom" align="left">114 (47.5%)</td>
<td valign="bottom" align="left">31 (47.7%)</td>
<td valign="bottom" align="left">0.978</td>
</tr>
<tr>
<td valign="bottom" align="left">Tracheal Intubation</td>
<td valign="bottom" align="left">161 (67.1%)</td>
<td valign="bottom" align="left">52 (80.0%)</td>
<td valign="bottom" align="left">0.044</td>
</tr>
<tr>
<td valign="bottom" align="left">Continuous Renal Replacement Therapy</td>
<td valign="bottom" align="left">28 (11.7%)</td>
<td valign="bottom" align="left">15 (23.1%)</td>
<td valign="bottom" align="left">0.019</td>
</tr>
<tr>
<td valign="bottom" align="left">Carbapenem-resistant Gram-negative Bacilli</td>
<td valign="bottom" align="left">159 (66.3%)</td>
<td valign="bottom" align="left">52 (80.0%)</td>
<td valign="bottom" align="left">0.033</td>
</tr>
<tr>
<td valign="bottom" align="left">Charlson Comorbidity Index score (scores)</td>
<td valign="bottom" align="left">4.00 (2.00, 6.00)</td>
<td valign="bottom" align="left">5.00 (3.00, 7.00)</td>
<td valign="bottom" align="left">0.071</td>
</tr>
<tr>
<td valign="bottom" align="left">SOFA Score (scores)</td>
<td valign="bottom" align="left">5.00 (4.00, 7.00)</td>
<td valign="bottom" align="left">7.00 (5.00, 11.00)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">APACHE II Score (scores)</td>
<td valign="bottom" align="left">17.00 (13.00, 21.00)</td>
<td valign="bottom" align="left">20.00 (17.00, 26.00)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">White Blood Cell Count (10<sup>9</sup>/L)</td>
<td valign="bottom" align="left">10.34 (7.70, 14.68)</td>
<td valign="bottom" align="left">9.41 (7.57, 14.56)</td>
<td valign="bottom" align="left">0.379</td>
</tr>
<tr>
<td valign="bottom" align="left">Platelet Count (10<sup>9</sup>/L)</td>
<td valign="bottom" align="left">194.00 (136.00, 284.00)</td>
<td valign="bottom" align="left">144.00 (89.00, 199.00)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">Hemoglobin (g/L)</td>
<td valign="bottom" align="left">103.50 (84.00, 125.00)</td>
<td valign="bottom" align="left">88.00 (72.00, 115.00)</td>
<td valign="bottom" align="left">0.004</td>
</tr>
<tr>
<td valign="bottom" align="left">Procalcitonin (ng/mL)</td>
<td valign="bottom" align="left">0.41 (0.13, 2.40)</td>
<td valign="bottom" align="left">3.37 (0.72, 6.80)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">C-reactive Protein (mg/L)</td>
<td valign="bottom" align="left">62.26 (29.00, 90.00)</td>
<td valign="bottom" align="left">75.84 (35.38, 90.00)</td>
<td valign="bottom" align="left">0.191</td>
</tr>
<tr>
<td valign="bottom" align="left">Interleukin-6 (pg/mL)</td>
<td valign="bottom" align="left">54.36 (17.57, 161.80)</td>
<td valign="bottom" align="left">263.20 (101.00, 461.10)</td>
<td valign="bottom" align="left">0.014</td>
</tr>
<tr>
<td valign="bottom" align="left">Lactic Acid (mmol/L)</td>
<td valign="bottom" align="left">1.68 (1.38, 2.30)</td>
<td valign="bottom" align="left">2.60 (1.70, 3.60)</td>
<td valign="bottom" align="left">0.007</td>
</tr>
<tr>
<td valign="bottom" align="left">Oxygenation Index</td>
<td valign="bottom" align="left">300.00 (228.00, 346.00)</td>
<td valign="bottom" align="left">285.00 (201.50, 328.00)</td>
<td valign="bottom" align="left">0.212</td>
</tr>
<tr>
<td valign="bottom" align="left">Serum Creatinine (&#xb5;mol/L)</td>
<td valign="bottom" align="left">71.70 (50.40, 103.20)</td>
<td valign="bottom" align="left">110.60 (60.40, 211.90)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">Bilirubin (&#xb5;mol/L)</td>
<td valign="bottom" align="left">11.30 (6.50, 16.40)</td>
<td valign="bottom" align="left">12.40 (7.00, 19.80)</td>
<td valign="bottom" align="left">0.295</td>
</tr>
<tr>
<td valign="bottom" align="left">Glasgow Coma Scale (scores)</td>
<td valign="bottom" align="left">8.00 (5.00, 10.00)</td>
<td valign="bottom" align="left">7.00 (5.00, 10.00)</td>
<td valign="bottom" align="left">0.885</td>
</tr>
<tr>
<td valign="bottom" align="left">Activated Partial Thromboplastin Time (seconds)</td>
<td valign="bottom" align="left">32.90 (26.40, 39.90)</td>
<td valign="bottom" align="left">38.65 (31.10, 46.25)</td>
<td valign="bottom" align="left">0.003</td>
</tr>
<tr>
<td valign="bottom" align="left">Prothrombin Time (seconds)</td>
<td valign="bottom" align="left">13.30 (12.10, 14.60)</td>
<td valign="bottom" align="left">14.50 (12.90, 16.55)</td>
<td valign="bottom" align="left">0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">Fibrinogen (g/L)</td>
<td valign="bottom" align="left">3.82 (2.41, 4.99)</td>
<td valign="bottom" align="left">3.71 (2.05, 4.81)</td>
<td valign="bottom" align="left">0.379</td>
</tr>
<tr>
<td valign="bottom" align="left">D-Dimer (mg/L)</td>
<td valign="bottom" align="left">3.39 (1.70, 6.53)</td>
<td valign="bottom" align="left">6.60 (2.99, 13.14)</td>
<td valign="bottom" align="left">0.003</td>
</tr>
<tr>
<td valign="bottom" align="left">Mechanical Ventilation Duration (days)</td>
<td valign="bottom" align="left">5.00 (0.00, 13.00)</td>
<td valign="bottom" align="left">8.00 (3.00, 14.00)</td>
<td valign="bottom" align="left">0.045</td>
</tr>
<tr>
<td valign="bottom" align="left">Hospital Stay Duration (days)</td>
<td valign="bottom" align="left">21.00 (14.50, 29.00)</td>
<td valign="bottom" align="left">15.00 (11.00, 21.00)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
<tr>
<td valign="bottom" align="left">ICU Stay Duration (days)</td>
<td valign="bottom" align="left">20.00 (13.00, 27.00)</td>
<td valign="bottom" align="left">13.00 (9.00, 18.00)</td>
<td valign="bottom" align="left">&lt;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Continuous variables not following a normal distribution are represented as median (interquartile range), and categorical variables are represented as cases (%).</p>
</fn>
<fn>
<p>SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation; ICU, Intensive Care Unit.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Multifactorial logistic regression analysis</title>
<p>The 30-day mortality of ICU patients with gram-negative bacillary pneumonia was a dependent variable. The variables assessed included the patients&#x2019; SOFA scores, platelet counts, procalcitonin, lactic acid, and APACHE II scores on the first day of ICU admission, whether the patient developed infectious shock, hypoalbuminemia, bloodstream infections, tracheal intubation, continuous renal replacement therapy, carbapenem-resistant gram-negative Bacilli, acute kidney injury, and duration of mechanical ventilation during the hospital stay. Using stepwise forward logistic regression with a significance level of P &lt; 0.05, we found that lactic acid (odds ratio (OR): 1.524, 95% CI: 1.057&#x2013;2.197), tracheal intubation (OR: 4.202, 95% CI: 1.092&#x2013;16.169), and acute kidney injury (OR: 4.776, 95% CI: 1.632&#x2013;13.978) were independent risk factors for 30-day mortality in ICU patients with gram-negative bacillary pneumonia. However, upon inclusion of bloodstream infections in a multifactorial logistic regression analysis, it was revealed that bloodstream infections are not an independent risk factor for 30-day mortality in ICU patients with Gram-negative bacterial pneumonia. The equation for the model is listed below. P=1/[1+exp [-(-3.999 + 0.421X1 + 1.435X2 + 1.564X3)]] (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Multifactorial logistic regression analysis of 30-day mortality in ICU patients with gram-negative bacilli infections.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="left">Variables</th>
<th valign="bottom" align="left">&#x3b2;</th>
<th valign="bottom" align="left">OR</th>
<th valign="bottom" align="left">95%CI</th>
<th valign="bottom" align="left">P-values</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">Lactic Acid (mmol/L) (X1)</td>
<td valign="bottom" align="left">0.421</td>
<td valign="bottom" align="left">1.524</td>
<td valign="bottom" align="left">1.057&#x2013;2.197</td>
<td valign="bottom" align="left">0.024</td>
</tr>
<tr>
<td valign="bottom" align="left">Tracheal Intubation (X2)</td>
<td valign="bottom" align="left">1.435</td>
<td valign="bottom" align="left">4.202</td>
<td valign="bottom" align="left">1.092&#x2013;16.169</td>
<td valign="bottom" align="left">0.037</td>
</tr>
<tr>
<td valign="bottom" align="left">Acute Kidney Injury (X3)</td>
<td valign="bottom" align="left">1.564</td>
<td valign="bottom" align="left">4.776</td>
<td valign="bottom" align="left">1.632&#x2013;13.978</td>
<td valign="bottom" align="left">0.004</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>b, beta values; OR, odds ratios; CI, confidence intervals.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Establishment of the nomogram prediction model</title>
<p>Three independent risk factors were identified using multiple logistic regression analysis. The StataSE15.0 software was used to construct a predictive model for 30-day mortality in ICU patients with pneumonia caused by infection with gram-negative bacilli, and a nomolog graph (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) was created. The regression coefficients of each variable were used to calculate corresponding scores, with acute kidney injury, an increase in blood lactate by 2 mmol/L, and tracheal intubation scoring 1.9, 1, and 1.7 points, respectively. The sum of the individual scores of each variable gives a total score, which corresponds to the probability of 30-day mortality in ICU patients with gram-negative bacillary pneumonia. The total score in the model ranged from 0 to 13.6 points. For example, an ICU patient with gram-negative bacillary pneumonia who experienced acute kidney injury, tracheal intubation, and a lactate level of 4 mmol/L would have a score of 5.6 points according to the nomogram, correlating to a 66% probability of 30-day mortality.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Nomogram predicting 30-day mortality in ICU patients with gram-negative pneumonia. In the figure, it can be seen that acute kidney injury (1.9 points), lactic acid (1 point for every 2 mmol increase), and tracheal intubation (1.7 points) are depicted. Then, the scores for each variable are summed to obtain the total score, which corresponds to the predicted probability of 30-day mortality in ICU patients with gram-negative bacillary pneumonia. For example, for a patient with gram-negative bacillary pneumonia in the ICU who experienced acute kidney injury, endotracheal intubation, and a lactate level of 4 mmol/L, according to the nomogram, the total score would be calculated as follows: 1.9 + 2 + 1.7 = 5.6 points, corresponding to a 66% probability of 30-day mortality.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1382755-g002.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Internal validation of the predictive model</title>
<p>The goodness of fit of the predictive model was assessed using the Hosmer-Lemeshow test, which showed a chi-square value of 5.770 and a P-value of 0.834, indicating a good fit (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). After plotting the ROC curve, the area under the curve was 0.791 (95% CI: 0.688&#x2013;0.893), suggesting that the predictive model was effective and had good discriminatory ability (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Internal validation was performed using the bootstrap method, with 1000 repeated samples of the original data yielding a C-index of 0.791 (0.690&#x2013;0.891), indicating that the model exhibited good discriminatory power. The decision curve revealed a high net benefit value for threshold probabilities between 0.15 and 0.9, indicating a high value for the predictive model (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Hosmer-Lemeshow test for the predictive model.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1382755-g003.tif"/>
</fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Receiver operating characteristic (ROC) curve for the predictive model.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1382755-g004.tif"/>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Decision curve analysis for the predictive model.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1382755-g005.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Average survival time of patients with low, medium, and high risk</title>
<p>Patients were categorized as low-, medium-, or high-risk based on the predicted probability of death within 30 days of hospitalization: scores less than 3.8 with a predicted probability of less than 30% were considered low risk; scores between 3.8 and 5.2 with a predicted probability greater than 30% and less than 60% were considered medium risk; and scores equal to or greater than 5.2 with a predicted probability equal to or greater than 60% were considered high risk. The outcome measure was 30-day mortality in ICU patients with gram-negative pneumonia, as depicted by the Kaplan-Meier survival curve. The median survival times were 30 (30, 30) days for low-risk patients, 30 (16.5, 30) days for medium-risk patients, and 17 (11, 27) days for high-risk patients, exhibiting statistically significant differences (P &lt; 0.001) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Kaplan-Meier survival curves for each risk stratification.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1382755-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>This retrospective study revealed the predominant bacterial strains causing gram-negative bacillary pneumonia in ICU patients, with Klebsiella pneumoniae being the most common pathogen identified, followed by Acinetobacter baumannii and Pseudomonas aeruginosa. Among the 305 patients included in the study, those who succumbed within 30 days exhibited significantly higher rates of septic shock, hypoalbuminemia, chronic renal insufficiency, and acute kidney injury, along with elevated SOFA and APACHE II scores. Multifactorial logistic regression analysis identified lactic acid, tracheal intubation, and acute kidney injury as independent risk factors for 30-day mortality in these patients. Moreover, a nomogram prediction model was developed, demonstrating good discriminatory ability and providing valuable insights into risk stratification for mortality prediction in ICU patients with gram-negative bacillary pneumonia. Overall, our study provides promising insights for critical care medicine, offering a robust framework for predicting mortality risk and informing targeted interventions to optimize patient care in the management of gram-negative bacillary pneumonia in the ICU.</p>
<p>The incidence of pneumonia caused by gram-negative bacilli has been reported to be increasing (<xref ref-type="bibr" rid="B2">Assefa, 2022</xref>; <xref ref-type="bibr" rid="B34">Solmaz and Kal&#x131;n, 2021</xref>; <xref ref-type="bibr" rid="B17">Guzek et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B12">Durdu et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B31">Radulescu and Gant, 2023</xref>), which is consistent with the findings of this study. ICU patients are often critically ill and immunocompromised, which makes them susceptible to opportunistic infections. Once infected with gram-negative bacilli, pneumonia can develop, increasing the patient&#x2019;s mortality and medical costs (<xref ref-type="bibr" rid="B28">Oliveira and Reygaert, 2023</xref>). Our results indicated a mortality rate of 21.3%, which aligns with a previous report showing a 23.1% mortality rate under the same conditions (<xref ref-type="bibr" rid="B14">Feng et&#xa0;al., 2019</xref>), suggesting that patients in the ICU with gram-negative bacterial pneumonia are prone to short-term mortality, and preventing and controlling the risk factors of death is essential to improving clinical outcomes.</p>
<p>The gender distribution observed in our study raises interesting questions regarding the epidemiology and susceptibility of gram-negative bacillary pneumonia in ICU settings in China, particularly at our institution. This gender disparity could reflect broader trends in the prevalence of risk factors for severe infections, including lifestyle factors, genetic predispositions, or access to care, which might differ significantly between genders (<xref ref-type="bibr" rid="B24">Mauvais-Jarvis et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B15">Gay et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B25">Migliore et&#xa0;al., 2021</xref>). Previous studies have suggested that males may have a higher incidence of certain risk factors for pneumonia, such as smoking and alcohol use, which could contribute to the increased susceptibility to infections, including gram-negative bacillary pneumonia (<xref ref-type="bibr" rid="B16">Groeneveld et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B9">Corica et&#xa0;al., 2022</xref>). Additionally, occupational exposure to pollutants or pathogens might be higher in males, depending on regional and socioeconomic contexts (<xref ref-type="bibr" rid="B4">Biswas et&#xa0;al., 2021</xref>). It&#x2019;s also possible that inherent biological differences, such as immune system function, could contribute to these disparities (<xref ref-type="bibr" rid="B4">Biswas et&#xa0;al., 2021</xref>). However, our study did not explicitly explore the reasons behind this gender distribution, and further research is needed to understand the underlying causes fully.</p>
<p>Logistic regression is a valuable tool for assessing disease risk factors and estimating disease occurrence probabilities under varied circumstances. Our investigation identified acute kidney injury, lactic acidosis, and tracheal intubation as independent risk factors for 30-day mortality among ICU patients infected with gram-negative bacterial pneumonia. A precedent inquiry established a nexus between renal dysfunction and mortality in 96 subjects grappling with carbapenem-resistant gram-negative bacterial pneumonia (<xref ref-type="bibr" rid="B33">Shen et&#xa0;al., 2022</xref>). Given the inflammatory nature of both pneumonia and acute kidney injury, an increased immune response could manifest in pneumonia patients concomitantly experiencing acute kidney injury, thereby complicating and exacerbating the condition while drastically diminishing survival prospects (<xref ref-type="bibr" rid="B26">Murugan et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B6">Chawla et&#xa0;al., 2017</xref>). Previous multivariate logistic regression analysis in pneumonia patients identified lactic acid levels as an additional independent mortality risk factor (<xref ref-type="bibr" rid="B10">Demirel, 2018</xref>). Gram-negative bacterial pneumonia sufferers frequently encounter multi-organ failure mainly attributable to hypoxia and insufficient perfusion. Lactic acid, a byproduct of anaerobic glucose fermentation, mirrors augmented anaerobic metabolism, serving as a direct indicator of tissue hypoxia and suboptimal perfusion, intricately linked with pneumonia severity and mortality risk (<xref ref-type="bibr" rid="B21">Liu et&#xa0;al., 2015</xref>). Furthermore, investigations have demonstrated a marked escalation in mortality risk among gram-negative bacterial pneumonia patients necessitating tracheal intubation (<xref ref-type="bibr" rid="B22">Lodise et&#xa0;al., 2021</xref>), consistent with our findings. These findings imply that individuals requiring tracheal intubation often present compromised pulmonary function, severe illness and diminished resistance to infection, rendering them particularly susceptible to mortality. Thus, to enhance the outcomes of individuals requiring tracheal intubation due to gram-negative bacterial pneumonia, comprehensive supportive care, including meticulous monitoring of pulmonary function, aggressive treatment of infections, and optimization of organ perfusion, should be prioritized, aiming to reduce mortality risks associated with their compromised condition.</p>
<p>The nomogram chart presents a novel predictive model characterized by high accuracy and ease of dissemination. In contrast to <xref ref-type="bibr" rid="B14">Feng et&#xa0;al. (2019)</xref>, who employed multivariate logistic regression analysis on 269 cases of gram-negative bacterial pneumonia to ascertain ICU admission as a mortality risk factor, our study directly focused on ICU patients afflicted with gram-negative bacterial pneumonia. By integrating clinically relevant indicators into the nomogram chart and employing multivariate logistic regression analysis to amalgamate multiple predictive indicators, complex data are transformed into a visually accessible format, enhancing the intuitive, rigorous, and practical aspects of the prediction model for patient risk assessment. Unlike studies such as <xref ref-type="bibr" rid="B3">Baek et&#xa0;al. (2020)</xref>, which solely utilized the area under the ROC curve to validate mortality predictive models in elderly patients with severe pneumonia, our research employed multiple validation methods, augmenting the credibility of the model. The Hosmer-Lemeshow test results affirm the good fit of the predictive model. With an area under the ROC curve of 0.791, our predictive model demonstrates effectiveness in forecasting the 30-day mortality risk among ICU patients with gram-negative bacterial pneumonia. Additionally, the decision curve analysis underscores a high net benefit and clinical value of the predictive model, further substantiating its utility in clinical practice.</p>
<p>Kaplan-Meier survival curve analysis serves as a method to depict survival time on the x-axis and survival rate on the y-axis, facilitating the assessment of certain factors&#x2019; impact on survival duration. In our investigation, we employed Kaplan-Meier survival curve analysis to evaluate the 30-day survival duration of patients categorized into low, medium, and high-risk groups based on the predictive model. The findings revealed a notable correlation between higher risk scores and shorter survival times. This stands in contrast to the study by <xref ref-type="bibr" rid="B33">Shen et&#xa0;al. (2022)</xref>, which solely identified mortality risk factors in patients with gram-negative bacterial pneumonia without stratifying patients by risk or examining their short-term survival. Moreover, our study supplemented the findings with graphical representations of Kaplan-Meier survival curves, enhancing their interpretability and applicability for clinicians. Overall, upon further validation, our proposed nomogram could help guide interventions and optimize patient care in ICU settings. By stratifying patients based on their risk of mortality, healthcare providers can tailor interventions to address specific needs and mitigate adverse outcomes. For instance, patients identified as high risk according to the predictive nomogram model may benefit from closer monitoring, aggressive management of complications such as acute kidney injury, and early initiation of appropriate antimicrobial therapy targeting multidrug-resistant pathogens. Moreover, risk-based interventions can help allocate limited healthcare resources effectively, ensuring that high-risk patients receive timely and targeted interventions to improve their chances of survival. By incorporating risk stratification into clinical practice, healthcare providers can enhance the precision and effectiveness of interventions, ultimately improving patient outcomes in ICU settings.</p>
<p>Despite our efforts to comprehensively analyze risk factors for mortality in ICU patients with gram-negative bacillary pneumonia, several limitations should be acknowledged. Firstly, our study did not specifically assess the impact of antibiotic therapy on patient outcomes, which represents an important aspect of pneumonia management that could influence mortality rates. Second, the retrospective nature of our study design may have introduced selection bias and limited our ability to establish causal relationships between identified risk factors and mortality. Third, our study was conducted at a single center without external validation, potentially limiting the generalizability of our findings to other patient populations and healthcare settings. In addition, the possibility of unmeasured confounding variables influencing our results cannot be entirely ruled out. Lastly, the potential multicollinearity between APACHE and SOFA scores as independent variables could be considered a limitation, though the VIF coefficients were below the threshold of 5 (2.94 for APACHE and 2.09 for SOFA). Further investigation into the impact of these limitations on our findings could provide additional insights in future studies.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>In conclusion, our findings reveal the important role of acute kidney injury, lactic acidosis and the need for tracheal intubation in determining the short-term mortality risk of ICU patients with gram-negative bacillary pneumonia. In regards to our proposed predictive model, this study provides important insights for devising a tool capable of early risk stratification, guiding more personalized and effective clinical interventions to improve the outcomes of these patients.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Medical Ethics Committee of the First Affiliated Hospital of Fujian Medical University [2015] 084-1. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>Q-XL: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Validation. ZF: Conceptualization, Data curation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. H-CZ: Conceptualization, Data curation, Methodology, Supervision, Validation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. YZ: Conceptualization, Data curation, Methodology, Writing &#x2013; review &amp; editing. PH: Data curation, Methodology, Writing &#x2013; review &amp; editing. HL: Data curation, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was funded by the Fujian Medical University Foundation (2021QH1082) 9.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arakawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Fujimori</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kondo</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Iba</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A new SOFA score calculation to improve the predictive performance for mortality in sepsis-associated disseminated intravascular coagulopathy patients</article-title>. <source>J. Crit. Care</source> <volume>64</volume>, <fpage>108</fpage>&#x2013;<lpage>113</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jcrc.2021.03.008</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assefa</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns</article-title>. <source>Pneumonia (Nathan)</source> <volume>14</volume>, <elocation-id>4</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s41479-022-00096-z</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>C. H.</given-names>
</name>
<name>
<surname>Hyun</surname> <given-names>I. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mortality and prognostic prediction in very elderly patients with severe pneumonia</article-title>. <source>J. Intensive Care Med.</source> <volume>35</volume>, <fpage>1405</fpage>&#x2013;<lpage>1410</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0885066619826045</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Harbin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Irvin</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Begum</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tiong</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Sex and gender differences in occupational hazard exposures: a scoping review of the recent literature</article-title>. <source>Curr. Environ. Health Rep.</source> <volume>8</volume>, <fpage>267</fpage>&#x2013;<lpage>280</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40572-021-00330-8</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casale</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Bianco</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Bastos</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Comini</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Corcione</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Boattini</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Prevalence and impact on mortality of colonization and super-infection by carbapenem-resistant gram-negative organisms in COVID-19 hospitalized patients</article-title>. <source>Viruses</source> <volume>15</volume>, <elocation-id>1934</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/v15091934</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chawla</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Amdur</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Faselis</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kimmel</surname> <given-names>P. L.</given-names>
</name>
<name>
<surname>Palant</surname> <given-names>C. E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Impact of acute kidney injury in patients hospitalized with pneumonia</article-title>. <source>Crit. Care Med.</source> <volume>45</volume>, <fpage>600</fpage>&#x2013;<lpage>606</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/CCM.0000000000002245</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheema</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Ellahi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>H. U.</given-names>
</name>
<name>
<surname>Kashif</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Adil</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials</article-title>. <source>J. Crit. Care</source> <volume>78</volume>, <elocation-id>154346</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jcrc.2023.154346</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cill&#xf3;niz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Domined&#xf2;</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria</article-title>. <source>Curr. Opin. Infect. Dis.</source> <volume>32</volume>, <fpage>656</fpage>&#x2013;<lpage>662</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/QCO.0000000000000596</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corica</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Tartaglia</surname> <given-names>F.</given-names>
</name>
<name>
<surname>D&#x2019;Amico</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Romiti</surname> <given-names>G. F.</given-names>
</name>
<name>
<surname>Cangemi</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Sex and gender differences in community-acquired pneumonia</article-title>. <source>Intern. Emerg. Med.</source> <volume>17</volume>, <fpage>1575</fpage>&#x2013;<lpage>1588</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11739-022-02999-7</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demirel</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Lactate levels and pneumonia severity index are good predictors of in-hospital mortality in pneumonia</article-title>. <source>Clin. Respir. J.</source> <volume>12</volume>, <fpage>991</fpage>&#x2013;<lpage>995</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/crj.12616</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dettori</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Portunato</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Vena</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Giacobbe</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Bassetti</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Severe infections caused by difficult-to-treat Gram-negative bacteria</article-title>. <source>Curr. Opin. Crit. Care</source> <volume>29</volume>, <fpage>438</fpage>&#x2013;<lpage>445</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MCC.0000000000001074</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durdu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kritsotakis</surname> <given-names>E. I.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>A. C. K.</given-names>
</name>
<name>
<surname>Torun</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Hakyemez</surname> <given-names>I. N.</given-names>
</name>
<name>
<surname>Gultepe</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Temporal trends and patterns in antimicrobial-resistant Gram-negative bacteria implicated in intensive care unit-acquired infections: A cohort-based surveillance study in Istanbul, Turkey</article-title>. <source>J. Glob. Antimicrob. Resist.</source> <volume>14</volume>, <fpage>190</fpage>&#x2013;<lpage>196</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jgar.2018.04.015</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Tseng</surname> <given-names>Y. H.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study</article-title>. <source>Ann. Intensive Care</source> <volume>13</volume>, <elocation-id>1</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13613-022-01088-4</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>D. Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y. Q.</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>X. L.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W. B.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X. X.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Factors influencing mortality in hospital-acquired pneumonia caused by Gram-negative bacteria in China</article-title>. <source>J. Infect. Public Health</source> <volume>12</volume>, <fpage>630</fpage>&#x2013;<lpage>633</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jiph.2019.02.014</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gay</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Melenotte</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lakbar</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Mezouar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Devaux</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Raoult</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Sexual dimorphism and gender in infectious diseases</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.698121</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groeneveld</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Ballering</surname> <given-names>A. V.</given-names>
</name>
<name>
<surname>van Boven</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Akkermans</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Olde Hartman</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Uijen</surname> <given-names>A. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Sex differences in incidence of respiratory symptoms and management by general practitioners</article-title>. <source>Fam. Pract.</source> <volume>37</volume>, <fpage>631</fpage>&#x2013;<lpage>636</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/fampra/cmaa040</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzek</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Korzeniewski</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Tomaszewski</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rybicki</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zwoli&#x144;ska</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Bacteriological assessment of pneumonia caused by gram-negative bacteria in patients hospitalized in intensive care unit</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>955</volume>, <fpage>39</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/5584_2016_163</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunton</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Updated concepts in the diagnosis and management of community-acquired pneumonia</article-title>. <source>JAAPA</source> <volume>32</volume>, <fpage>18</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/01.JAA.0000580528.33851.0c</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanj</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Bassetti</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kiratisin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Villegas</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>60</volume>, <elocation-id>106633</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2022.106633</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kofteridis</surname> <given-names>D. P.</given-names>
</name>
<name>
<surname>Andrianaki</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Maraki</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mathioudaki</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Plataki</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Alexopoulou</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Treatment pattern, prognostic factors, and outcome in patients with infection due to pan-drug-resistant gram-negative bacteria</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>39</volume>, <fpage>965</fpage>&#x2013;<lpage>970</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10096-019-03784-9</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Clinical significance of dynamic monitoring of blood lactic acid, oxygenation index and C-reactive protein levels in patients with severe pneumonia</article-title>. <source>Exp. Ther. Med.</source> <volume>10</volume>, <fpage>1824</fpage>&#x2013;<lpage>1828</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2015.2770</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lodise</surname> <given-names>T. P.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Law</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Spilsbury-Cantalupo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>McCart</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Eaddy</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Hospital readmissions and mortality among intubated and mechanically ventilated adult subjects with pneumonia due to gram-negative bacteria</article-title>. <source>Respir. Care</source> <volume>66</volume>, <fpage>742</fpage>&#x2013;<lpage>750</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4187/respcare.07754</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>G. H.</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mechanism of drug resistance in gram-negative bacteria</article-title>. <source>Guide China Med.</source> <volume>7</volume>, <fpage>45</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.3969/j.issn.1671-8194.2009.11.023</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mauvais-Jarvis</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bairey Merz</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Barnes</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Brinton</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Carrero</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>DeMeo</surname> <given-names>D. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Sex and gender: modifiers of health, disease, and medicine</article-title>. <source>Lancet</source> <volume>396</volume>, <fpage>565</fpage>&#x2013;<lpage>582</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(20)31561-0</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Migliore</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nicol&#xec;</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Stoccoro</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gender specific differences in disease susceptibility: the role of epigenetics</article-title>. <source>Biomedicines</source> <volume>9</volume>, <elocation-id>652</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biomedicines9060652</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murugan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Karajala-Subramanyam</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yende</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Carter</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival</article-title>. <source>Kidney Int.</source> <volume>77</volume>, <fpage>527</fpage>&#x2013;<lpage>535</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ki.2009.502</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naved</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Siddiqui</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>F. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>APACHE-II score correlation with mortality and length of stay in an intensive care unit</article-title>. <source>J. Coll. Phys. Surg. Pak.</source> <volume>21</volume>, <fpage>4</fpage>&#x2013;<lpage>8</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Reygaert</surname> <given-names>W. C.</given-names>
</name>
</person-group> (<year>2023</year>). &#x201c;<article-title>Gram-Negative Bacteria</article-title>,&#x201d; in <source>StatPearls</source> (<publisher-name>StatPearls Publishing</publisher-name>, <publisher-loc>Treasure Island (FL</publisher-loc>).</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palevsky</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>K. D.</given-names>
</name>
<name>
<surname>Brophy</surname> <given-names>P. D.</given-names>
</name>
<name>
<surname>Chawla</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Parikh</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Thakar</surname> <given-names>C. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury</article-title>. <source>Am. J. Kidney Dis.</source> <volume>61</volume>, <fpage>649</fpage>&#x2013;<lpage>672</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.ajkd.2013.02.349</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pugh</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Grant</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cooke</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Dempsey</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>8</volume>, <elocation-id>CD007577</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/14651858.CD007577.pub3</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radulescu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gant</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Gram-negative pulmonary infections - advances in epidemiology and diagnosis</article-title>. <source>Curr. Opin. Pulm. Med.</source> <volume>29</volume>, <fpage>168</fpage>&#x2013;<lpage>173</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MCP.0000000000000957</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sader</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Castanheira</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mendes</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Flamm</surname> <given-names>R. K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres, (2015&#x2013;17)</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>73</volume>, <fpage>3053</fpage>&#x2013;<lpage>3059</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dky279</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>W. W.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>X. Q.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>A. Q.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Risk factors of carbapenem-resistant gram-negative bacteria pneumonia and mortality</article-title>. <source>Cell Mol. Biol. (Noisy-le-grand)</source> <volume>68</volume>, <fpage>124</fpage>&#x2013;<lpage>129</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.14715/cmb/2022.68.10.20</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solmaz</surname> <given-names>&#x130;.</given-names>
</name>
<name>
<surname>Kal&#x131;n</surname> <given-names>B. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Assessment of antibiotic resistance of infectious agents in patients with pneumonia in tertiary critical care unit and effect on clinical outcomes</article-title>. <source>Int. J. Clin. Pract.</source> <volume>75</volume>, <elocation-id>e13872</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ijcp.13872</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>